RecruitingPhase 3NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Sponsor: Merck Sharp & Dohme LLCFairfax, VA · Norfolk, VA · Richmond, VA · +51 more sites
RecruitingPhase 3NCT06841354A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Sponsor: Merck Sharp & Dohme LLCNorfolk, VA · +38 more sites
RecruitingPhase 3NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Sponsor: Merck Sharp & Dohme LLCMidlothian, VA · Norfolk, VA · Roanoke, VA · +61 more sites
RecruitingPhase not listedNCT07330258A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsSponsor: BayerCharlottesville, VA · Norfolk, VA · +25 more sites